Alkermes (ALKS) FCF Margin (2010 - 2026)
Alkermes (ALKS) posted quarterly FCF Margin of 27.63% for Q2 2026, down 749.0% year-over-year from 4.26% in Q2 2025, and up 163.92% quarter-over-quarter from 43.22% in Q1 2026.
Alkermes (ALKS) FCF Margin (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported FCF Margin for 17 consecutive years, with 27.63% the latest figure, recorded in Q2 2026.
- In Q2 2026, FCF Margin fell 749.0% year-over-year to 27.63%; the TTM figure through Jun 2026 stood at 13.29% (down 1859.0% YoY), while the FY2025 annual figure was 32.55%, up 650.0% from the prior year.
- FCF Margin grew to 27.63% in Q2 2026 per ALKS's latest filing, from 43.22% in the prior quarter.
- Across five years, FCF Margin topped out at 44.23% in Q4 2025 and bottomed at 383.38% in Q2 2022.
- Historically, FCF Margin has averaged 22.52% across 5 years, with a median of 21.89% in 2023.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 39210 bps — and 2023, when it jumped 41674 bps.
- Alkermes' FCF Margin stood at 2.95% in 2022, then soared by 911 bps to 23.9% in 2023, then soared by 76 bps to 42.01% in 2024, then climbed by 5 bps to 44.23% in 2025, then sank by 38 bps to 27.63% in 2026.
- Business Quant data shows ALKS's FCF Margin at 27.63% in Q2 2026, 43.22% in Q1 2026, and 44.23% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 27.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.63% |
| Mar 31, 2026 | -43.22% |
| Dec 31, 2025 | 44.23% |
| Sep 30, 2025 | 21.40% |
| Jun 30, 2025 | 35.12% |
| Mar 31, 2025 | 28.94% |
| Dec 31, 2024 | 42.01% |
| Sep 30, 2024 | 19.39% |
| Jun 30, 2024 | 34.81% |
| Mar 31, 2024 | 3.64% |
| Dec 31, 2023 | 23.90% |
| Sep 30, 2023 | 22.38% |
| Jun 30, 2023 | 33.37% |
| Mar 31, 2023 | -9.79% |
| Dec 31, 2022 | -2.95% |
| Sep 30, 2022 | -307.78% |
| Jun 30, 2022 | -383.38% |
| Mar 31, 2022 | 4.99% |
| Dec 31, 2021 | 6.89% |
| Sep 30, 2021 | 26.51% |